- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 52.7M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $391.75M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $510.03M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $13.84M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $24.11M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $276.49M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $455.08M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.16B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.13B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.63B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.33B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.27B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.08B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.49B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.29B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.45B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.24B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 52.52M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $10.43M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $98.27M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.30 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $66.45M |
| Net Income | Q1 2025 · Mar 31, 2024 | $15.76M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $48.81M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $115.25M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $933.74M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.05B |